{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T21:17:53Z","timestamp":1794777473100,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["UG1 EY033703-01A1"],"award-info":[{"award-number":["UG1 EY033703-01A1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY002162"],"award-info":[{"award-number":["EY002162"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajo.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:29:46Z","timestamp":1778729386000},"page":"20-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Visual Field Progression in Glaucoma Patients With Delayed Follow-Up"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-8636","authenticated-orcid":false,"given":"AJAY","family":"KOLLI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EVAN","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XINYI","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5976-949X","authenticated-orcid":false,"given":"JENNY","family":"LU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATRICK","family":"TAKLA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2935-7356","authenticated-orcid":false,"given":"JILL","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MATTHEW","family":"HUH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUAN","family":"ZHAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8287-0756","authenticated-orcid":false,"given":"JADYN","family":"LEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KELLY","family":"NGUYEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ETHAN","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-1257","authenticated-orcid":false,"given":"YINXI","family":"YU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4825-1522","authenticated-orcid":false,"given":"STEPHEN D.","family":"MCLEOD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOSHUA D.","family":"STEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"STEVEN J.","family":"GEDDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TIN","family":"AUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FEI","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PRADEEP","family":"RAMULU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GUI-SHUANG","family":"YING","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8131-7971","authenticated-orcid":false,"given":"YING","family":"HAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ajo.2026.05.007_bib0001","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jamaophthalmol.2024.3884","article-title":"Prevalence of glaucoma among US adults in 2022","volume":"142","author":"Ehrlich","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.007_bib0002","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1167\/iovs.15-18469","article-title":"Prevalence of glaucoma in the United States: the 2005-2008 National Health and nutrition examination survey","volume":"57","author":"Gupta","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.007_bib0003","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamaneurol.2022.0723","article-title":"Addition of vision impairment to a life-course model of potentially modifiable dementia risk factors in the US","volume":"79","author":"Ehrlich","year":"2022","journal-title":"JAMA Neurol"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.007_bib0004","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/IJG.0000000000002213","article-title":"Adherence of those with self-reported glaucoma in the United States to eye examination visits","volume":"32","author":"Hou","year":"2023","journal-title":"J Glaucoma"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.007_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ophtha.2023.09.018","article-title":"Ophthalmology workforce projections in the United States, 2020 to 2035","volume":"131","author":"Berkowitz","year":"2024","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.007_bib0006","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/09286586.2021.1968006","article-title":"The prevalence of diagnosis of major eye diseases and their associated payments in the Medicare fee-for-service program","volume":"30","author":"Wittenborn","year":"2023","journal-title":"Ophthalmic Epidemiology"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0007","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archophthalmol.2011.224","article-title":"Influence of visual field testing frequency on detection of glaucoma progression with trend analyses","volume":"129","author":"Nouri-Mahdavi","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.007_bib0008","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.ophtha.2017.01.027","article-title":"Frequency of testing to detect visual field progression derived using a longitudinal cohort of glaucoma patients","volume":"124","author":"Wu","year":"2017","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0009","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1001\/jamaophthalmol.2021.0341","article-title":"Assessment of cumulative incidence and severity of primary open-angle glaucoma among participants in the ocular hypertension treatment study after 20 years of follow-up","volume":"139","author":"Kass","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0010","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ophtha.2020.06.009","article-title":"Risk factors for visual field deterioration in the United Kingdom Glaucoma treatment study","volume":"127","author":"Founti","year":"2020","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.007_bib0011","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1167\/iovs.14-14643","article-title":"Rates of glaucomatous visual field change in a large clinical population","volume":"55","author":"Chauhan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2026.05.007_bib0012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2020.05.019","article-title":"Rates of glaucomatous structural and functional change from a large clinical population: the Duke Glaucoma Registry Study","volume":"222","author":"Jammal","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.007_bib0013","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2017.06.003","article-title":"Risk factors for rapid Glaucoma disease progression","volume":"180","author":"Chan","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.007_bib0014","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1167\/iovs.13-13006","article-title":"Examining visual field loss in patients in Glaucoma clinics during their predicted remaining lifetime","volume":"55","author":"Saunders","year":"2014","journal-title":"Investigat Ophthalmol Visual Sci"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.007_bib0015","doi-asserted-by":"crossref","DOI":"10.1111\/aos.12788","article-title":"Progression of visual field in patients with primary open-angle glaucoma \u2013 ProgF Study 1","volume":"93","author":"Aptel","year":"2015","journal-title":"Acta Ophthalmologica"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0016","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1755-3768.2012.02492.x","article-title":"Rates of visual field progression in clinical glaucoma care","volume":"91","author":"Heijl","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0017","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ophtha.2023.01.008","article-title":"Fast progressors in Glaucoma: prevalence based on global and Central visual field loss","volume":"130","author":"Jackson","year":"2023","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0018","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0008-4182(06)80025-6","article-title":"Canadian glaucoma study: 1. study design, baseline characteristics, and preliminary analyses","volume":"41","year":"2006","journal-title":"Can J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0019","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/eye.2015.161","article-title":"Are rates of vision loss in patients in English Glaucoma clinics slowing down over time? trends from a decade of data","volume":"29","author":"Boodhna","year":"2015","journal-title":"Eye"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0020","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamaophthalmol.2022.0671","article-title":"Rates of visual field change in patients with glaucoma and healthy individuals: findings from a median 25-year follow-up","volume":"140","author":"Giammaria","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.007_bib0021","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bjo.2007.135012","article-title":"Practical recommendations for measuring rates of visual field change in glaucoma","volume":"92","author":"Chauhan","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0022","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/archophthalmol.2011.224","article-title":"Influence of visual field testing frequency on detection of glaucoma progression with trend analyses","volume":"129","author":"Nouri-Mahdavi","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.007_bib0023","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1167\/iovs.15-16444","article-title":"Barriers to follow-up and strategies to improve adherence to appointments for care of chronic eye diseases","volume":"56","author":"Thompson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.007_bib0024","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/09286586.2022.2127787","article-title":"Loss to follow up among glaucoma patients at a tertiary eye center over 10 years: incidence, risk factors, and clinical outcomes","volume":"30","author":"Williams","year":"2023","journal-title":"Ophthal Epidemiol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0025","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1007\/s00417-013-2490-5","article-title":"A Modified glaucoma staging system based on visual field index","volume":"251","author":"Hirasawa","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0026","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ophtha.2022.12.025","article-title":"Validation of rates of mean deviation change as clinically relevant endpoints for glaucoma progression","volume":"130","author":"Medeiros","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.05.007_bib0027","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2147\/OPTH.S94497","article-title":"Relationship between consecutive deterioration of mean deviation value and progression of visual field defect in open-angle glaucoma","volume":"9","author":"Naito","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.007_bib0028","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-34009-x","article-title":"A Potential primary endpoint for clinical trials in glaucoma neuroprotection","volume":"13","author":"De Moraes","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.007_bib0029","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ogla.2019.01.004","article-title":"Improving the feasibility of Glaucoma clinical trials using trend-based visual field progression endpoints","volume":"2","author":"Wu","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"10.1016\/j.ajo.2026.05.007_bib0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2021.04.008","article-title":"Improving the power of glaucoma neuroprotection trials using existing visual field data","volume":"229","author":"Montesano","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.007_bib0031","article-title":"Impact of different visual field testing paradigms on sample size requirements for glaucoma clinical trials","volume":"8","author":"Wu","year":"2018","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.007_bib0032","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ogla.2025.05.006","article-title":"Short-term rates of visual field change predict glaucoma progression","volume":"8","author":"Adelpour","year":"2025","journal-title":"Ophthalmol Glaucoma"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.007_bib0033","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0161-6420(98)91134-4","article-title":"Risk factors for noncompliance with glaucoma follow-up visits in a residents\u2019 eye clinic","volume":"105","author":"Kosoko","year":"1998","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30201-3","article-title":"Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov Model","volume":"7","author":"Tang","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ajo.2026.05.007_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ajo.2017.05.017","article-title":"Optimizing glaucoma screening in high-risk population: design and 1-year findings of the screening to prevent (SToP) glaucoma study","volume":"180","author":"Zhao","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.007_bib0036","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IJG.0000000000001812","article-title":"Michigan screening and intervention for glaucoma and Eye health through telemedicine (MI-SIGHT): baseline methodology for implementing and assessing a community-based program","volume":"30","author":"Newman-Casey","year":"2021","journal-title":"J Glaucoma"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.007_bib0037","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.1167\/iovs.14-15040","article-title":"Clustering visual field test points based on rates of progression to improve the prediction of future damage","volume":"55","author":"Hirasawa","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.007_bib0038","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ophtha.2016.11.011","article-title":"Myocilin predictive genetic testing for primary open-angle glaucoma leads to early identification of at-risk individuals","volume":"124","author":"Souzeau","year":"2017","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.007_bib0039","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.8.2.10","article-title":"Polygenic risk score is associated with intraocular pressure and improves glaucoma prediction in the UK biobank cohort","volume":"8","author":"Gao","year":"2019","journal-title":"Trans Vis Sci Tech"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0040","first-page":"1820","article-title":"Philadelphia telemedicine glaucoma detection and follow-up study: confirmation between eye screening and comprehensive eye examination diagnoses","volume":"103","author":"Hark","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113779","article-title":"The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis","volume":"9","author":"Thomas","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ajo.2026.05.007_bib0042","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2019.4190","article-title":"Accuracy of Kalman filtering in forecasting visual field and intraocular pressure trajectory in patients with ocular hypertension","volume":"137","author":"Garcia","year":"2019","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.007_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.survophthal.2022.08.005","article-title":"Automatic detection of glaucoma via fundus imaging and artificial intelligence: a review","volume":"68","author":"Coan","year":"2023","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.007_bib0044","article-title":"Novel approaches for the early detection of glaucoma using artificial intelligence","volume":"14","author":"Zeppieri","year":"2024","journal-title":"Life (Basel)"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.007_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0236819","article-title":"Baseline structural characteristics of the optic nerve head and retinal nerve fiber layer are associated with progressive visual field loss in patients with open-angle glaucoma","volume":"15","author":"Siesky","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.007_bib0046","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1167\/iovs.13-12261","article-title":"Baseline prognostic factors predict rapid visual field deterioration in glaucoma","volume":"55","author":"Lee","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.007_bib0047","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest Glaucoma trial","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2026.05.007_bib0048","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ajo.2019.06.019","article-title":"Risk factors for fast visual field progression in glaucoma","volume":"207","author":"Kim","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.007_bib0049","article-title":"Primary open-angle Glaucoma preferred practice pattern\u00ae","volume":"128","author":"Gedde","year":"2021","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.007_bib0050","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ophtha.2021.09.022","article-title":"Racial and socioeconomic differences in eye care utilization among Medicare beneficiaries with glaucoma","volume":"129","author":"Halawa","year":"2022","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T20:52:36Z","timestamp":1794775956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426002400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S0002939426002400"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Visual Field Progression in Glaucoma Patients With Delayed Follow-Up","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}